期刊文献+

Manumycin与DDP、PYM、5-FU、ADR联合的体外抗舌癌作用 被引量:1

In vitro Anti-cancer Effect of Manumycin Administered in Combination with Cisplatin,Pingyangmycin,5-Fluorouracil or Adriamycin on Carcinoma of the Tongue
暂未订购
导出
摘要 目的:探讨Manumycin(手霉素)与常用舌癌化疗药物顺铂、5-氟脲嘧啶、平阳霉素、阿霉素联合作用于舌鳞癌Tca8113的细胞毒作用。方法:细胞毒测定以MTT法;单药细胞毒测定以半倍浓度梯度设计;联合用药细胞毒测定以ChouTC中效原理设计。结果:Manumycin以及顺铂、5-氟脲嘧啶、平阳霉素、阿霉素单独应用对Tca8113均有明显的细胞毒作用。联合用药显示在相应比例剂量条件下,Manumycin与顺铂联合(3.75:1)后呈拮抗作用,Manumycin与5-氟脲嘧啶联合(0.75:1)作用后,低浓度联合相互拮抗,而高浓度联合时明显协同,Manumycin与平阳霉素(0.75:1)、阿霉素联合(30:1)作用后呈相互协同的作用(CI<1)。结论:Manumycin与平阳霉素、阿霉素以及与5-氟脲嘧啶高浓度联合作用于Tca8113细胞呈相互协同的细胞毒作用。 Objective: To investigate the cytotoxic effect of manumycin combined individually with cisplatin (DDP), 5-fluorouracil (5-FU), pingyangmycin (PYM) and adriamycin (ADR) on carcinoma of the tongue. Methods: Cytotoxicity of manumycin was determined by MTT assay, and cytotoxicity of the other drugs alone was determined using the half concentration gradient design. The cytotoxicity of each drug administered in combination with manumycin was determined by the Chou TC lente-principle design. Results: Each drug applied singly showed an obvious cytotoxicity on Tca8113 tongue carcinoma cells. Combined administration of each drug with manumycin showed that with a dosage of corresponding ratio, manumycin produced an antagonism (3.75:1) as combined with Cisplatin, showed a combined mutual antagonism (0.75:1) with a low concentration when combined with 5-Fu and the synergism was overt as with a high concentration. The mutual synergism was shown after joint action of manumycin with Pingyangmycin (0.75:1) and with Adriamycin (30:1) (CI〈I). Conclusion: The combination of manumycin with PYM and the combination of ADR, manumycin and 5-Fu at high concentration showed synergistic cytotoxicity to Tca8113 cells in vitro (CI〈I).
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第15期867-870,共4页 Chinese Journal of Clinical Oncology
关键词 MANUMYCIN 联合用药 舌癌 Manumycin Combined administration of drugs Carcinoma of tongue
  • 相关文献

参考文献10

  • 1Hara M, Akasaka K, Akinaga S, et al. Identification of Ras farnesyltransferase inhibitors by microbial screening [J]. Proc Natl Acad Sci USA, 1993, 90(6):2281-2285
  • 2Reddy EP, Reynolds RK, Santos E, et al. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene [J]. Nature, 1982, 300(5888):149-152
  • 3Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions[]]. Endocr Rev, 2001, 22 (2):153-183
  • 4许彦枝,王晓玲,唐全勇,张洁英,左连富,刘忆林.舌癌及癌前病变ras癌基因产物P^(21)和DNA倍体的研究[J].中华物理医学杂志,1998,20(1):60-61. 被引量:1
  • 5Xu G, Pan j, Martin C, et al. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma [J]. Clin Endocrinol Metab, 2001, 86(4):1769-1777
  • 6Caponigro F. Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer[J]. Andcancer Drugs, 2004, 15 (4):311-320
  • 7Harada K, Supriatno, Yoshida H, et al. Vesnarinone inhibits anbiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8 [J]. Int J Oncol, 2005, 27 (6):1489 - 1497
  • 8Fu LW, Zhang YM, L iang YJ, et al. The multidrug resistance of tumor cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF27 / adr cells[J]. EurJ Cancer, 2002, 38(3):418-426
  • 9Chou TC, Motzer RJ, Tong Y, et al. Computerized quantitation of synergism and antagonism of taxol, topotecan.and cisplatin against human teratocarcinoma cells growth: a rational approach to clinical protocal design [J].J Nail Cancer Inst, 1994, 86(20):1517-1524
  • 10陈姝,汤为学,娄世锋.中效原理在体外抗癌药物定量分析中的应用[J].肿瘤防治研究,2004,31(5):270-272. 被引量:8

二级参考文献6

  • 1刘新月,齐凤英,侯琳,焦建平,张祥宏,左连富.癌基因ras P^(21)在口腔癌前病变和鳞癌表达的定量研究[J].中华口腔医学杂志,1995,30(4):225-228. 被引量:3
  • 2Chou TC,Talalay P.Quantitative analysis of dose-effects relationships:the combined effect of multiple drugs on enzyme inhibitors[J].Adv Enzyme Regul,1984,22:27-55.
  • 3Ting Chao Chou,Robert JM,YouZhi Tong,et al.Computeriged quantitation of synergism and antagonism of Taxol,Topotecan,and Cisplatin against human teratocarcinoma cell growth:a rational approach to clinical protocol design[J].Journal of the National cancer I
  • 4Scott HK,David P,Christopher AB,et al.Cytotoxic effects of Topotecan.Combined with various anticancer agents in human cancer cell lines[J].Journal of the National Cancer Institute,1996,88(11):734-741.
  • 5Hayley MM,Patrick GJ.Synergistic Interaction between paclitaxel and 8-Chloro-adenosine 3',5'-Monophosphate in human orarian Carcinoma Cell Lines[J].Clin Cancer Res,1999,5(1):215-220.
  • 6汤为学,骆云鹏,王瑞雪.人实体瘤抗癌药物敏感试验MTT法的建立[J].重庆医科大学学报,1992,17(2):103-108. 被引量:97

共引文献7

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部